Pharmaceuticals segment accounted for the largest market size in the specialty enzymes

The specialty enzymes market was valued at USD 4.4 billion in 2019 and is projected to reach USD 6.6 billion by 2025, recording a CAGR of 6.9% during the forecast period. The demand for enzymes is increasing significantly, as it is being used across various specialty applications and as a substitute for chemical catalysts.

Download PDF Brochure

By application, the pharmaceuticals segment accounted for the largest market size in the specialty enzymes market during the forecast period. The demand for specialty enzymes is increasing significantly due to the increasing application of enzymes in the pharmaceutical industry. 

Specialty enzyme usage in the pharmaceutical industry is mainly for drug manufacture, disease diagnostics, or as therapy. Increasing incorporation of enzymes in therapies for diseases such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management, among others, is a factor that fuels market demand.


The polymerases & nucleases segment is projected to dominate the market during the forecast period. Polymerases & nucleases are used in specialty applications, such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. 

North America accounted for the largest market share in the specialty enzymes market. Technological advancements in this region have made enzymes available for a wide range of applications, and this segment is estimated to drive the growth of the market in the region.

Key players in the global market include BASF (Germany), DuPont (US), Roche Holding (Switzerland), Novozymes (Denmark), DSM (Netherlands), Sanofi (France), and Codexis (US).

Comments

Popular posts from this blog

Global Bottled Water Processing Market: Key Trends and Insights by 2028

Growth Trends and Opportunities in the Global Edible Oils Market

Transformative Growth Projected for Global Seed Coating Market: A Comprehensive Overview